Page last updated: 2024-10-31

metoclopramide and Colorectal Cancer

metoclopramide has been researched along with Colorectal Cancer in 1 studies

Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.

Research Excerpts

ExcerptRelevanceReference
"Intestinal obstruction is a relatively common clinical problem in patients with advanced cancer, particularly those with colorectal and ovarian tumours."1.28Non-operative management of malignant intestinal obstruction. ( Elder, P; Isbister, WH; Symons, L, 1990)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Isbister, WH1
Elder, P1
Symons, L1

Other Studies

1 other study available for metoclopramide and Colorectal Cancer

ArticleYear
Non-operative management of malignant intestinal obstruction.
    Journal of the Royal College of Surgeons of Edinburgh, 1990, Volume: 35, Issue:6

    Topics: Adult; Aged; Colorectal Neoplasms; Drug Combinations; Female; Humans; Infusions, Intravenous; Intest

1990